General MedicationsTOPICALStandard
NAFTIFINE HYDROCHLORIDE
NAFTIFINE HYDROCHLORIDE
Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Key Takeaways
- Primary indication: Review priority: STANDARD Marketing status: Prescription
- Approval overview NAFTIFINE HYDROCHLORIDE is listed in Drugs@FDA under application 205975 (ANDA).
- Review priority: STANDARD Marketing status: Prescription Active ingredient NAFTIFINE HYDROCHLORIDE Form and strength CREAM;TOPICAL - 1% Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2019-12-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview NAFTIFINE HYDROCHLORIDE is listed in Drugs@FDA under application 205975 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NAFTIFINE HYDROCHLORIDE Form and strength CREAM;TOPICAL - 1% Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2019-12-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.